PR 879-317A enhances in vitro immune activity of peripheral blood mononuclear cells from patients with down syndrome
- 1 January 1987
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 9 (8) , 919-926
- https://doi.org/10.1016/0192-0561(87)90008-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- INTERFERONS AND NATURAL KILLER CELLSBritish Medical Bulletin, 1985
- Association of decreased T-cell-mediated natural cytotoxicity and interferon production in Down's SyndromeClinical Immunology and Immunopathology, 1984
- Effects of levamisole on human natural killer and killer cell activity and production of interferonsImmunopharmacology, 1982
- STUDIES OF THE RESPONSE IN MIXED LEUKOCYTE CULTURE OF CELLS FROM PATIENTS WITH APLASTIC ANEMIA TO CELLS FROM HLA-IDENTICAL SIBLINGSTransplantation, 1981
- Mechanism of Cell-Mediated Cytotoxicity at the Single Cell LevelThe Journal of Immunology, 1979
- Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivorsBlood, 1978
- DIRECT AND ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY AGAINST HLA IDENTICAL SIBLING LYMPHOCYTESTransplantation, 1976
- Effect of Levamisole on E-Rosette-Forming Cells in Vivo and in Vitro in Hodgkin's DiseaseNew England Journal of Medicine, 1976
- LEVAMISOLE AND LYMPHOCYTE RESPONSIVENESSThe Lancet, 1975